115 related articles for article (PubMed ID: 8119767)
61. High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies.
Gernert M; Kiesel M; Fröhlich M; Renner R; Strunz PP; Portegys J; Tony HP; Schmalzing M; Schwaneck EC
Front Immunol; 2021; 12():789345. PubMed ID: 34868076
[TBL] [Abstract][Full Text] [Related]
62. Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections.
Kriek JM; Jaumdally SZ; Masson L; Little F; Mbulawa Z; Gumbi PP; Barnabas SL; Moodley J; Denny L; Coetzee D; Williamson AL; Passmore JA
Virology; 2016 Jun; 493():247-54. PubMed ID: 27065342
[TBL] [Abstract][Full Text] [Related]
63. Treatment with interferon for genital HPV in HIV-positive and HIV-negative women.
Semprini AE; Stillo A; Marcozzi S; Castagna C; Fiore S; Radaelli U
Eur J Obstet Gynecol Reprod Biol; 1994 Feb; 53(2):135-7. PubMed ID: 7910799
[TBL] [Abstract][Full Text] [Related]
64. Anal carcinoma in an HIV-infected woman.
Sendagorta E; Herranz P; Guadalajara H; Zamora FX; Gonzalez J
ScientificWorldJournal; 2010 Jun; 10():986-7. PubMed ID: 20526528
[TBL] [Abstract][Full Text] [Related]
65. The role of human papillomavirus in gynecological diseases.
Nuovo GJ
Crit Rev Clin Lab Sci; 2000 Jun; 37(3):183-215. PubMed ID: 10894184
[TBL] [Abstract][Full Text] [Related]
66. Is use of hormone replacement therapy associated with increased detection of human papillomavirus and potential risk of HPV-related genital cancers?
Smith EM; Levy BT; Ritchie JM; Jia J; Wang D; Haugen TH; Turek LP
Eur J Cancer Prev; 2002 Jun; 11(3):295-305. PubMed ID: 12131663
[TBL] [Abstract][Full Text] [Related]
67. More on extragenital HPV-16(+) lesions.
Fader DJ
Int J Dermatol; 1994 May; 33(5):390. PubMed ID: 8039982
[No Abstract] [Full Text] [Related]
68. [Atypical cutaneous infections with genital HPV].
Grussendorf-Conen EI
Hautarzt; 2011 Jan; 62(1):22-7. PubMed ID: 21181103
[TBL] [Abstract][Full Text] [Related]
69. Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics.
Offidani A; Radi G; Bianchi L; Cannavò SP; Conti A; Gesuita R; Salaffi F; Talamonti M; Campanati A
Eur J Dermatol; 2021 Aug; 31(4):493-498. PubMed ID: 34642139
[TBL] [Abstract][Full Text] [Related]
70. Cutaneous infections by papillomavirus, herpes zoster and Candida albicans as the only manifestation of idiopathic CD4+ T lymphocytopenia.
Manchado Lopez P; Ruiz de Morales JM; Ruiz González I; Rodriguez Prieto MA
Int J Dermatol; 1999 Feb; 38(2):119-21. PubMed ID: 10192160
[TBL] [Abstract][Full Text] [Related]
71. Interferon system in women with genital papillomavirus infection receiving immunomodulatory therapy.
Rogovskaya SI; Zhdanov AV; Loginova NS; Faizullin LZ; Prilepskaya VN; Van'ko LV; Sukhikh GT
Bull Exp Biol Med; 2002 Nov; 134(5):463-6. PubMed ID: 12802453
[TBL] [Abstract][Full Text] [Related]
72. Immunopathogenesis of HIV encephalitis.
Achim CL; Schrier RD; Wiley CA
Brain Pathol; 1991 Apr; 1(3):177-84. PubMed ID: 1669706
[TBL] [Abstract][Full Text] [Related]
73. An unusual presentation of vulvar carcinoma in a HIV patient.
Giorda G; Vaccher E; Volpe R; DePiero G; Tirelli U; Scarabelli C
Gynecol Oncol; 1992 Feb; 44(2):191-4. PubMed ID: 1544598
[TBL] [Abstract][Full Text] [Related]
74. Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus.
Soriano V; Bravo R; Mas A; García-Samaniego J; Guiérrez M; González-Lahoz J
Vox Sang; 1995; 69(3):259-60. PubMed ID: 8578743
[No Abstract] [Full Text] [Related]
75. [Tuberculosis and immunosuppression].
Mayaud C; Le Pendeven C; Cadranel J; Denis M
Rev Med Interne; 1995; 16 Suppl 1():38s-41s. PubMed ID: 7652237
[No Abstract] [Full Text] [Related]
76. Exuberant oral lesions in an immunocompromised patient.
Garbelini Lima Forneck C; Evangelista de Almeida G; Pastore MC; de Souza Cavalcante A; Gomes de Souza ML
JAAD Case Rep; 2021 Feb; 8():40-42. PubMed ID: 33490345
[No Abstract] [Full Text] [Related]
77. Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women.
González C; Canals J; Ortiz M; Muñoz L; Torres M; García-Saiz A; Del Amo J
Epidemiol Infect; 2008 Feb; 136(2):215-21. PubMed ID: 17445312
[TBL] [Abstract][Full Text] [Related]
78. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
79. Human papillomavirus typing in HIV-positive women.
Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
[TBL] [Abstract][Full Text] [Related]
80. Will New Human Papillomavirus Diagnostics Improve Cervical Cancer Control Efforts?
Kulasingam SL; Koutsky LA
Curr Infect Dis Rep; 2001 Apr; 3(2):169-182. PubMed ID: 11286660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
